"non small cell lung" trang 12 - tải miễn phí từ tailieuXANH
Significant correlation between urinary N1 , N12-diacetylspermine and tumor invasiveness in patients with clinical stage IA non-small cell lung cancer

Significant correlation between urinary N1 , N12-diacetylspermine and tumor invasiveness in patients with clinical stage IA non-small cell lung cancer
8    66    0
Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: A single center retrospective analysis

Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: A single center retrospective analysis
10    61    0
Prognostic value of secreted phosphoprotein-1 in pleural effusion associated with non-small cell lung cancer

Prognostic value of secreted phosphoprotein-1 in pleural effusion associated with non-small cell lung cancer
8    91    0
A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer

A phase II study of cisplatin with intravenous and oral vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy with oral vinorelbine and cisplatin for locally advanced non-small cell lung cancer
9    55    0
Simultaneous expression of flotillin-1, flotillin-2, stomatin and caveolin-1 in non-small cell lung cancer and soft tissue sarcomas

Simultaneous expression of flotillin-1, flotillin-2, stomatin and caveolin-1 in non-small cell lung cancer and soft tissue sarcomas
9    56    0
FUT4siRNA augments the chemosensitivity of non-small cell lung cancer to cisplatin through activation of FOXO1-induced apoptosis

FUT4siRNA augments the chemosensitivity of non-small cell lung cancer to cisplatin through activation of FOXO1-induced apoptosis
10    52    0
Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy

Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy
5    51    0
Expressions of MUC1 and vascular endothelial growth factor mRNA in blood are biomarkers for predicting efficacy of gefitinib treatment in non-small cell lung cancer

Expressions of MUC1 and vascular endothelial growth factor mRNA in blood are biomarkers for predicting efficacy of gefitinib treatment in non-small cell lung cancer
11    56    0
Prognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancer

Prognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancer
10    73    0
The efficacy and safety of crizotinib in the treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer: A meta-analysis of clinical trials

The efficacy and safety of crizotinib in the treatment of anaplastic lymphoma kinase-positive non-small cell lung cancer: A meta-analysis of clinical trials
6    51    0
MicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18

MicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18
8    56    0
Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer

Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer
10    58    0
Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer

Cyclin-dependent kinase-specific activity predicts the prognosis of stage I and stage II non-small cell lung cancer
10    59    0
Radiation dose and survival of patients with stage IV non-small cell lung cancer undergoing concurrent chemotherapy and thoracic three-dimensional radiotherapy: Reanalysis of the findings of a single-center prospective study

Radiation dose and survival of patients with stage IV non-small cell lung cancer undergoing concurrent chemotherapy and thoracic three-dimensional radiotherapy: Reanalysis of the findings of a single-center prospective study
8    72    0
Fluorodeoxyglucose positron emission tomography and chemotherapy-related tumor marker expression in non-small cell lung cancer

Fluorodeoxyglucose positron emission tomography and chemotherapy-related tumor marker expression in non-small cell lung cancer
8    51    0
Analytic performance studies and clinical reproducibility of a real-time PCR assay for the detection of epidermal growth factor receptor gene mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer

Analytic performance studies and clinical reproducibility of a real-time PCR assay for the detection of epidermal growth factor receptor gene mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer
10    64    0
Usefulness of Serum Carcinoembryonic Antigen (CEA) in evaluating response to chemotherapy in patients with advanced non small-cell lung cancer: A prospective cohort study

Usefulness of Serum Carcinoembryonic Antigen (CEA) in evaluating response to chemotherapy in patients with advanced non small-cell lung cancer: A prospective cohort study
7    48    0
Overall survival and toxicities regarding thoracic three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small cell lung cancer: Results of a prospective single-center study

Overall survival and toxicities regarding thoracic three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small cell lung cancer: Results of a prospective single-center study
9    52    0
Evaluation of a curcumin analog as an anti-cancer agent inducing ER stress-mediated apoptosis in non-small cell lung cancer cells

Evaluation of a curcumin analog as an anti-cancer agent inducing ER stress-mediated apoptosis in non-small cell lung cancer cells
9    174    0
Concurrent chemoradiotherapy with tomotherapy in locally advanced non-small cell lung cancer: A phase i, docetaxel dose-escalation study, with hypofractionated radiation regimen

Concurrent chemoradiotherapy with tomotherapy in locally advanced non-small cell lung cancer: A phase i, docetaxel dose-escalation study, with hypofractionated radiation regimen
7    56    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.